Frontiers Current Pharmacological Strategies for Duchenne

Frontiers Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics

Advancing Precision Medicine in Paediatrics: Past, present and future, Cambridge Prisms: Precision Medicine

Frontiers Elucidation of bioinformatic-guided high-prospect drug repositioning candidates for DMD via Swanson linking of target-focused latent knowledge from text-mined categorical metadata

Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy

Anti-inflammatory nanoparticles significantly improve muscle function in a murine model of advanced muscular dystrophy

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

EMA starts review of Italfarmaco's Duchenne drug

PDF) Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy